Haleon (HLN) EBIT Margin (2021 - 2023)
Haleon (HLN) posted EBIT Margin of 20.21% for Q4 2023, up 8.2% on a QoQ basis from 18.68% in Q2 2023, and down 3571.0% year-over-year from 0.58% in Q4 2022.
Haleon (HLN) EBIT Margin (2021 - 2023) Analysis & Trends
Haleon's EBIT Margin history runs 3 years deep, the most recent figure standing at 20.21% for Q4 2023.
- Quarterly EBIT Margin fell 3571.0% year-over-year to 20.21% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 25.39% (changed N/A YoY) and the FY2025 annual result came in at 21.87%, up 223.0% from the prior year.
- EBIT Margin was 20.21% for Q4 2023 at Haleon, up from 18.68% in the prior quarter.
- Across five years, EBIT Margin topped out at 55.92% in Q4 2022 and bottomed at 17.61% in Q4 2021.
- A 3-year average of 26.68% and a median of 20.21% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin jumped 3831 bps — and 2023, when it slumped 3571 bps.
- Haleon's EBIT Margin stood at 17.61% in 2021, then surged by 218 bps to 55.92% in 2022, then tumbled by 64 bps to 20.21% in 2023.
- Business Quant data shows HLN's EBIT Margin at 20.21% in Q4 2023, 18.68% in Q2 2023, and 21.0% in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 8.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 20.21% |
| Jun 30, 2023 | 18.68% |
| May 3, 2023 | 21.00% |
| Dec 31, 2022 | 55.92% |
| Dec 31, 2021 | 17.61% |